BamSEC and AlphaSense Join Forces
Learn More

Edgewise Therapeutics Inc. – Indentures

NASDAQ: EWTX    
Share price (7/8/26): $46.30    
Market cap (7/8/26): $4.982 billion

Indentures Filter

EX-4.4
from S-3ASR 48 pages Edgewise Therapeutics, Inc. Indenture Dated as of [ ] Trustee
12/34/56
EX-4.5
from S-3 52 pages Edgewise Therapeutics, Inc. Indenture Dated as of , 20 [ ] Trustee
12/34/56
EX-4.3
from 10-K 7 pages Description of Capital Stock
12/34/56
EX-4.2
from S-1/A 2 pages Specimenspecimen Numbershares C-Edgewise Therapeutics, Inc. This Certifies That: Incorporated Under the Laws of the State of Delaware C O M M O N S T O C K See Reverse for Certain Definitions Cusip28036f105 Specimen - Not Negotiable Is the Owner of Fully Paid and Non-Assessable Shares of Common Stock of $0.0001 Par Value Each of Edgewise Therapeutics, Inc. Transferable on the Books of the Corporation by the Holder Thereof in Person or by Duly Authorized Attorney Upon Surrender of This Certificate Duly Endorsed or Assigned. This Certificate and the Shares Represented Hereby Are Subject to the Laws of the State of Delaware, and to the Certificate of Incorporation and Bylaws of the Corporation, as Now or Hereafter Amended. This Certificate Is Not Valid Until Countersigned by the Transfer Agent. Witness the Facsimile Seal of the Corporation and the Facsimile Signatures of Its Duly Authorized Officers. Dated: By: Broadridge Corporate Issuer Solutions, Inc. Transfer Agent Authorized Signature Specimen Not Negotiable General Counsel and Secretarypresident and Chief Executive Officer
12/34/56
EX-4.1
from S-1 51 pages Edgewise Therapeutics, Inc. Amended and Restated Investors’ Rights Agreement
12/34/56
EX-4.1
from DRS 51 pages Edgewise Therapeutics, Inc. Amended and Restated Investors’ Rights Agreement
12/34/56